secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2023-02-06T23:59:59+00:00
Accession:  0000950170-23-001812
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

MAIA restates Q3 2022 financials; ratchet shares and warrants misclassified
---------------------------------------------------------------------------

- Restating unaudited condensed balance sheet, income statement, comprehensive loss, equity, and cash flows as of and for periods ended Sep 30, 2022.
- Ratchet shares to pre-IPO investors were improperly recorded as a deemed dividend instead of an operating expense.
- Underwriter warrants issued in IPO were improperly classified as equity instead of a liability.
- Material weakness in internal control over financial reporting and ineffective disclosure controls identified.
- Restatement does not affect the company's cash position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000095017023001812/0000950170-23-001812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000095017023001812/maia-20230203.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer